Prestige Brand

Yahoo Finance • 6 days ago

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the op... Full story

Yahoo Finance • 8 days ago

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 100% Above Its Share Price

Key Insights Prestige Consumer Healthcare's estimated fair value is US$128 based on 2 Stage Free Cash Flow to Equity Prestige Consumer Healthcare is estimated to be 50% undervalued based on current share price of US$63.96 The US$82.80 ana... Full story

Yahoo Finance • 12 days ago

ASX Stocks Estimated To Be Up To 48.2% Below Intrinsic Value

As the Australian market navigates the complexities of interest rate decisions and fluctuating sector performances, investors are keenly observing opportunities in undervalued stocks. In such a climate, identifying stocks that are trading... Full story

Yahoo Finance • 24 days ago

Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Prestige Consumer Healthcare Inc. stands amongst them. Prestige Consumer Healthcare Inc. (NYSE:PBH), a global developer of OTC health and... Full story

Yahoo Finance • 27 days ago

Prestige Consumer Healthcare Becomes Oversold (PBH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • last month

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All inte... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: Premium Brands Q2 2025 sees stock surge despite EPS miss

Premium Brands Holdings Corporation (PBH) reported its Q2 2025 earnings, revealing a mixed financial performance. The company missed its earnings per share (EPS) forecast, posting an actual EPS of $1.33 against a projected $1.36, represent... Full story

Yahoo Finance • 2 months ago

Premium Brands Q2 2024 slides: Record revenue and EBITDA amid U.S. expansion

Introduction & Market Context Premium Brands Holdings Corporation (TSX:PBH) presented its second quarter 2024 results on August 8, 2024, highlighting record performance and continued momentum in its growth strategy. The specialty food man... Full story

Yahoo Finance • 3 months ago

Prestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital Age

We recently published 10 Most Undervalued Pharma Stocks To Buy Now.Prestige Consumer Healthcare Inc. stands first on our list and is accelerating digital shift and boosting retail speed. Prestige Consumer Healthcare Inc. (NYSE:PBH) tops t... Full story

Yahoo Finance • 3 months ago

Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results

TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the marke... Full story

Yahoo Finance • 3 months ago

Premium Brands Q1 2025 slides: Record revenue fueled by U.S. expansion strategy

Introduction & Market Context Premium Brands Holdings Corporation (TSX:PBH) presented its first quarter 2025 results during a conference call on May 7, 2025, highlighting record quarterly sales and adjusted EBITDA despite ongoing market c... Full story

Yahoo Finance • 4 months ago

Notable Two Hundred Day Moving Average Cross - PBH

In trading on Thursday, shares of Prestige Consumer Healthcare Inc (Symbol: PBH) crossed below their 200 day moving average of $61.03, changing hands as low as $59.89 per share. Prestige Consumer Healthcare Inc shares are currently tradin... Full story

Yahoo Finance • 4 months ago

Medtech recalls Little Remedies honey cough syrup over contamination

TARRYTOWN, N.Y. - Medtech Products Inc., a subsidiary of Prestige Consumer Healthcare Inc. (NYSE: PBH), a $4.1 billion consumer healthcare company with strong financial health according to InvestingPro metrics, announced Tuesday a voluntar... Full story

Yahoo Finance • 4 months ago

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

TARRYTOWN, N.Y., June 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference virtuall... Full story

Yahoo Finance • 6 months ago

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results

TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening... Full story

Yahoo Finance • 8 months ago

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

Revenue of $290.3 million in Q3, up 2.7% versus prior yearDiluted EPS of $1.22 in Q3 increased approximately 15% versus prior yearReduced leverage to 2.5x in Q3, driven by strong profitability and cash flowRaising full-year fiscal 2025 ear... Full story

Yahoo Finance • last year

Oppenheimer lists 5 retail stocks investors should own for 2025

Investing.com -- Oppenheimer in a note dated Wednesday flagged five key retail stocks that they believe investors should seriously consider as part of their portfolios heading into 2025. The stocks identified—Church&Dwight Co (NYSE:CHD),... Full story

Yahoo Finance • 2 years ago

Prestige Consumer Healthcare Inc. (PBH) Reports Modest Revenue and EPS Growth in Q3 Fiscal 2024

Revenue: Q3 revenue increased by 2.6% year-over-year to $282.7 million. Net Income: Q3 net income rose to $53.0 million, a 2.2% increase from the previous year. Earnings Per Share (EPS): Diluted EPS for Q3 was $1.06, up from $1.04 year-ove... Full story

Yahoo Finance • 2 years ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Prestige Consumer Healthcare Inc. Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior Year Diluted EPS of $1.06 in Q3, Up 2.2% Versus Prior Year Reduced Leverage Ratio to 2.9x at Quarter End Raising Full-Year Fiscal 2024 Earnings Outloo... Full story

Yahoo Finance • 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Prestige Consumer Healthcare Inc. Americaine® 20% Benzocaine Topical Anesthetic Spray Americaine® 20% Benzocaine Topical Anesthetic Spray TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Hea... Full story